Activated protein C does not alleviate the course of systemic inflammation in the APCAP trial

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Kyhälä, Lea ^a   Mentula, Panu ^a   Kylänpää, Leena ^a   Moilanen, Eeva ^b   Puolakkainen, Pauli ^a   Pettilä, Ville ^a   Repo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; DROTRECOGIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; PLACEBO; PROCALCITONIN;

ACUTE PANCREATITIS; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 84876511470     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/712739     Document Type: Article

References (36)

1. Grönroos J. M., Nylamo E. I., Mortality in acute pancreatitis in Turku University Central Hospital 19711995. Hepato-Gastroenterology 1999 46 28 2572 2574 2-s2.0-0032853705 (Pubitemid 29454145)
2. Mofidi R., Madhavan K. K., Garden O. J., Parks R. W., An audit of the management of patients with acute pancreatitis against national standards of practice. British Journal of Surgery 2007 94 7 844 848 2-s2.0-34447336182 10.1002/bjs.5670 (Pubitemid 47051208)
3. Repine J. E., Scientific perspectives on adult respiratory distress syndrome. The Lancet 1992 339 8791 466 469 2-s2.0-0026528858 10.1016/0140-6736(92)91067-I
4. Rau B., Steinbach G., Gansauge F., Mayer J. M., Grünert A., Beger H. G., The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997 41 6 832 840 2-s2.0-0031435062 (Pubitemid 28023189)
5. Aoun E., Chen J., Reighard D., Gleeson F. C., Whitcomb D. C., Papachristou G. I., Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: a meta-analysis. Pancreatology 2010 9 6 777 785 2-s2.0-75149165288 10.1159/000214191
6. Štimac D., davor.stimac@ri.htnet.hr Fišić E., Milić S., Bilić-Zulle L., Perić R., Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. Journal of Clinical Gastroenterology 2006 40 3 209 212 10.1097/00004836-200603000-00007 (Pubitemid 44309552)
7. Mayer J., Rau B., Gansauge F., Beger H. G., Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000 47 4 546 552 2-s2.0-0033804768 10.1136/gut.47.4.546
8. Hynninen M., Valtonen M., Markkanen H., Vaara M., Kuusela P., Jousela I., Piilonen A., Takkunen O., Interleukin 1 receptor antagonist and E-selectin concentrations: a comparison in patients with severe acute pancreatitis and severe sepsis. Journal of Critical Care 1999 14 2 63 68 2-s2.0-0033031968 10.1016/S0883-9441(99)90015-1 (Pubitemid 29278262)
9. Mentula P., panu.mentula@saunalahti.fi Kylänpää M.-L., Kemppainen E., Jansson S.-E., Sarna S., Puolakkainen P., Haapiainen R., Repo H., Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scandinavian Journal of Gastroenterology 2004 39 2 178 187 10.1080/00365520310008278 (Pubitemid 38253632)
10. Kylänpää-Bäck M. L., Takala A., Kemppainen E. A., Puolakkainen P. A., Leppäniemi A. K., Karonen S. L., Orpana A., Haapiainen R. K., Repo H., Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Critical Care Medicine 2001 29 1 63 69 2-s2.0-0035144603 (Pubitemid 32125776)
11. Powell J. J., Siriwardena A. K., Fearon K. C. H., Ross J. A., Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Critical Care Medicine 2001 29 3 567 572 2-s2.0-0035106664 (Pubitemid 32225299)
12. Pezzilli R., Corsi M. M., Barassi A., Morselli-Labate A. M., D A., Dogliotti G., Fantini L., Malesci A., Corinaldesi R., Melzi D'Eril G., Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severity. Pancreas 2008 37 1 36 41 2-s2.0-49649105262 10.1097/MPA.0b013e31816074df
13. Kylänpää-Bäck M.-L., Takala A., Kemppainen E., Puolakkainen P., Kautiainen H., Jansson S. E., Haapiainen R., Repo H., Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scandinavian Journal of Gastroenterology 2001 36 10 1100 1107 10.1080/003655201750422738 (Pubitemid 32801698)
14. Rahman S. H., Verbeke C. S., Gomez D., McMahon M. J., Menon K. V., Pancreatico-duodenectomy for complicated groove pancreatitis. HPB 2007 9 3 229 234 2-s2.0-34250655316 10.1080/13651820701216430 (Pubitemid 46939119)
15. Mentula P., Kylänpää-Bäck M. L., Kemppainen E., Takala A., Jansson S. E., Kautiainen H., Puolakkainen P., Haapiainen R., Repo H., Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clinical Science 2003 105 4 409 417 2-s2.0-0141923125 10.1042/CS20030058 (Pubitemid 37249166)
16. Richter A., Nebe T., Wendl K., Schuster K., Klaebisch G., Quintel M., Lorenz D., Post S., Trede M., HLA-DR expression in acute pancreatitis. European Journal of Surgery 1999 165 10 947 951 2-s2.0-0032717881 10.1080/ 110241599750008053 (Pubitemid 29503060)
17. Toltl L. J., Austin R. C., Liaw P. C., Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by reculating endoplasmic reticulum calcium depletion in blood monocytes. Journal of Thrombosis and Haemostasis 2010 9 582 592
18. Esmon C. T., The protein C anticoagulant pathway. Arteriosclerosis and Thrombosis 1992 12 2 135 145 2-s2.0-0026591793
19. Xu J., Esmon N. L., Esmon C. T., Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. The Journal of Biological Chemistry 1999 274 10 6704 6710 2-s2.0-0033525831 10.1074/jbc.274.10.6704 (Pubitemid 29111091)
20. Sarangi P. P., Lee H. W., Kim M., Activated protein C action in inflammation. British Journal of Haematology 2010 148 6 817 833 2-s2.0-77649224137 10.1111/j.1365-2141.2009.08020.x
21. Levi M., m.m.levi@amc.uva.nl Ten Cate H., Disseminated intravascular coagulation. The New England Journal of Medicine 1999 341 8 586 592 10.1056/NEJM199908193410807 (Pubitemid 29384168)
22. Lindstrom O., Kylanpaa L., Mentula P., Puolakkainen P., Kemppainen E., Haapiainen R., Fernandez J. A., Griffin J. H., Repo H., Petaja J., Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Critical Care 2006 10 1, article R16 2-s2.0-33846028402 10.1186/cc3966 (Pubitemid 47079805)
23. Bernard G. R., gordon.bernard@mcmail.vanderbilt.edu Vincent J.-L., Laterre P.-F., LaRosa S. P., Dhainaut J.-F., Lopez-Rodriguez A., Steingrub J. S., Garber G. E., Helterbrand J. D., Ely E. W., Fisher C. J., Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England Journal of Medicine 2001 344 10 699 709 10.1056/NEJM200103083441001 (Pubitemid 32204987)
24. Pettila V., Kyhala L., Kylanpaa M. L., Leppaniemi A., Tallgren M., Markkola A., Puolakkainen P., Repo H., Kemppainen E., APCAPactivated protein C in acute pancreatitis: a double-blind randomized human pilot trial. Critical Care 2010 R139 2-s2.0-77954885617 10.1186/cc9203
25. Opal S. M., DePalo V. A., Anti-inflammatory cytokines. Chest 2000 117 4 1162 1172 2-s2.0-0034090602 (Pubitemid 30228378)
26. Yuda H., Adachi Y., Taguchi O., Gabazza E. C., Hataji O., Fujimoto H., Tamaki S., Nishikubo K., Fukudome K., D'Alessandro-Gabazza C. N., Maruyama J., Izumizaki M., Iwase M., Homma I., Inoue R., Kamada H., Hayashi T., Kasper M., Lambrecht B. N., Barnes P. J., Suzuki K., Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood 2004 103 6 2196 2204 2-s2.0-12144291151 10.1182/blood-2003-06-1980 (Pubitemid 38326238)
27. Okajima K., Regulation of inflammatory responses by natural anticoagulants. Immunological Reviews 2001 184 258 274 2-s2.0-0035707639 10.1034/j.1600-065x.2001.1840123.x (Pubitemid 34123781)
28. Stephenson D. A., Toltl L. J., Beaudin S., Liaw P. C., Modulation of monocyte function by activated protein C, a natural anticoagulant. Journal of Immunology 2006 177 4 2115 2122 2-s2.0-33746888276 (Pubitemid 44200969)
29. Galley H. F., El Sakka N. E., Webster N. R., Lowes D. A., Cuthbertson B. H., Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. British Journal of Anaesthesia 2008 100 6 815 819 2-s2.0-44649103920 10.1093/bja/aen079 (Pubitemid 351774323)
30. Yuksel M., Okajima K., Uchiba M., Horiuchi S., Okabe H., Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor- α production by inhibiting activation of both nuclear factor- κ B and activator protein-1 in human monocytes. Thrombosis and Haemostasis 2002 88 2 267 273 2-s2.0-0036339949 (Pubitemid 34873708)
31. Toltl L. J., Beaudin S., Liaw P. C., pliaw@thrombosis.hhscr.org Winston B., Ward M., Hutchison J. S., Fox-Robichaud A., Leger C., Kubes P., Fraser D., Dos Santos C., McIntyre L., Martin C., Activated protein C up-regulates IL-10 and inhibits tissue factor in blood monocytes. Journal of Immunology 2008 181 3 2165 2173
32. Grinnell B. W., Gerlitz B., Berg D. T., Identification of a region in protein C involved in thrombomodulin-stimulated activation by thrombin: potential repulsion at anion-binding site I in thrombin. Biochemical Journal 1994 303, part 3 929 933 2-s2.0-0028006634 (Pubitemid 24326031)
33. Joyce D. E., Gelbert L., Ciaccia A., DeHoff B., Grinnell B. W., Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. The Journal of Biological Chemistry 2001 276 14 11199 11203 2-s2.0-0035815747 10.1074/jbc.C100017200 (Pubitemid 38089304)
34. Nick J. A., Coldren C. D., Geraci M. W., Poch K. R., Fouty B. W., O'Brien J., Gruber M., Zarini S., Murphy R. C., Kuhn K., Richter D., Kast K. R., Abraham E., Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004 104 13 3878 3885 2-s2.0-10244229104 10.1182/blood-2004- 06-2140 (Pubitemid 39620133)
35. Sturn D. H., Kaneider N. C., Feistritzer C., Djanani A., Fukudome K., Wiedermann C. J., Expression and function of the endothelial protein C receptor in human neutrophils. Blood 2003 102 4 1499 1505 2-s2.0-0043240071 10.1182/blood-2002-12-3880 (Pubitemid 36988062)
36. Bernard G. R., Ely E. W., Wright T. J., Fraiz J., Stasek J. E., Russell J. A., Mayers I., Rosenfeld B. A., Morris P. E., Yan S. B., Helterbrand J. D., Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Critical Care Medicine 2001 29 11 2051 2059 2-s2.0-0035164538 (Pubitemid 33063531)